Jaypirca 00002-7026
Generic: Pirtobrutinib
Product NDC
00002-7026- Manufacturer
- Eli Lilly And Company
- Dosage Form
- Tablet, Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 27, 2023
- Listing Expires
- December 31, 2027
- Application
- NDA216059
Need to source Jaypirca? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pirtobrutinib | 100 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]Bruton's Tyrosine Kinase Inhibitors [MoA]
Packaging Options(2)
60 TABLET, COATED in 1 BOTTLE (0002-7026-60)
30 TABLET, COATED in 1 BOTTLE (0002-7026-99)